Advancing the Manufacture of Patient Accessible Cell and Gene Therapies at Place-of-Care

Initially, UMass Chan researchers will work with Trenchant BioSystems to evaluate blood products to separate stem cells and build the automated gene transfer genetic engineering platform with Caring Cross lentiviral vectors.

The post Advancing the Manufacture of Patient Accessible Cell and Gene Therapies at Place-of-Care appeared first on GEN - Genetic Engineering and Biotechnology News.